Black Diamond Therapeutics (BDTX) Total Current Liabilities (2018 - 2021)
Historic Total Current Liabilities for Black Diamond Therapeutics (BDTX) over the last 4 years, with Q3 2021 value amounting to $26.4 million.
- Black Diamond Therapeutics' Total Current Liabilities rose 13243.98% to $26.4 million in Q3 2021 from the same period last year, while for Sep 2021 it was $26.4 million, marking a year-over-year increase of 13243.98%. This contributed to the annual value of $14.2 million for FY2020, which is 19237.1% up from last year.
- Latest data reveals that Black Diamond Therapeutics reported Total Current Liabilities of $26.4 million as of Q3 2021, which was up 13243.98% from $23.5 million recorded in Q2 2021.
- In the past 5 years, Black Diamond Therapeutics' Total Current Liabilities registered a high of $26.4 million during Q3 2021, and its lowest value of $2.6 million during Q4 2018.
- In the last 4 years, Black Diamond Therapeutics' Total Current Liabilities had a median value of $11.3 million in 2020 and averaged $12.8 million.
- In the last 5 years, Black Diamond Therapeutics' Total Current Liabilities surged by 8885.44% in 2019 and then skyrocketed by 28257.05% in 2021.
- Quarter analysis of 4 years shows Black Diamond Therapeutics' Total Current Liabilities stood at $2.6 million in 2018, then skyrocketed by 88.85% to $4.9 million in 2019, then skyrocketed by 192.37% to $14.2 million in 2020, then soared by 85.41% to $26.4 million in 2021.
- Its Total Current Liabilities stands at $26.4 million for Q3 2021, versus $23.5 million for Q2 2021 and $18.7 million for Q1 2021.